Страница 107 из 119
10. 55-відсоткове рішення
1. Malcolm Champion et al., eds., Optimal Management of IBD: Role of the Primary Care Physician (Toronto: The Medicine Group, 2001).
2. G. Moser et al., “Inflammatory Bowel Disease: Patients’ Beliefs about the Etiology of Their Disease—A Controlled Study,” Psychosomatic Medicine 55 (1993), 131, cited in R. Maunder, “Mediators of Stress Effects in Inflammatory Bowel Disease: Not the Usual Suspects,” Journal of Psychosomatic Research 48 (2000), 569–77.
3. G. L. Engel, as paraphrased in G. F. Solomon et al., “Immunity, Emotions, and Stress,” A
4. G. L. Engel, “Studies of Ulcerative Colitis III:The Nature of the Psychological Process,” American Journal of Medicine 19 (1955), 31, cited in A. Watkins, ed., Mind-Body Medicine:A Clinician’s Guide to Psychoneuroimmunology (New York: Churchill Livingstone, 1997), 140.
5. D. A. Drossman, “Presidential Address: Gastrointestinal Illness and the Biopsychosocial Model,” Psychosomatic Medicine 60 (1998): 258–67.
6. S. R. Targan, “Biology of Inflammation in Crohn’s Disease: Mechanisms of Action of Anti-TNF-Alpha Therapy,” Canadian Journal of Gastroenterology: Update on Liver and Inflammatory Bowel Disease, vol. 14, supplement C (September 2000).
7. H. Anisman et al., “Neuroimmune Mechanisms in Health and Disease: 1: Health,”
Canadian Medical Association Journal 155, no. 7 (1 October 1996), 872.
8. Drossman, “Presidential Address,” 265.
9. S. Levenstein et al., “Stress and Exacerbation in Ulcerative Colitis: A Prospective Study of Patients Enrolled in Remission,” American Journal of Gastroenterology 95, no. 5, 1213–20.
10. Noel Hershfield, “Hans Selye, Inflammatory Bowel Disease and the Placebo Response,” Canadian Journal of Gastroenterology 11, no. 7 (October 1997): 623–24.